BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
4 hedge funds and large institutions have $1.03M invested in BIMI International Medical Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
5,117% more capital invested
Capital invested by funds: $19.8K → $1.03M (+$1.01M)
100% more funds holding
Funds holding: 2 → 4 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$418K |
| 2 |
JP Morgan Chase
New York
|
+$103K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$424 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $779K | +$418K | +986 | +24,650% |
|
|
2
JP Morgan Chase
New York
| $190K | +$103K | +242 | New |
|
|
RE
3
RBC Europe
London,
United Kingdom
| $62.9K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $1K | +$424 | +1 | New |
|
BIMI Hedge Fund Activity: Q4 2018 in Review
4 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q4 2018, worth a combined $1.03M — up 5,117% from $19.8K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIMI positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $418K.
- 4 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q4 2018, up from 2 in Q3 2018.
- Funds reported $1.03M of BIMI International Medical Inc. Common Stock stock for Q4 2018, up 5,117% quarter-over-quarter.
- 2 funds opened new BIMI International Medical Inc. Common Stock positions in Q4 2018 and 0 closed out, a net change of +2 holders.
- The largest BIMI International Medical Inc. Common Stock buyer in Q4 2018 was Morgan Stanley, an estimated $418K added.
Based on aggregated 13F filings for Q4 2018.